Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Follicular regulatory T cells inhibit the development of granzyme B–expressing follicular helper T cells
Markus M. Xie, Shuyi Fang, Qiang Chen, Hong Liu, Jun Wan, Alexander L. Dent
Markus M. Xie, Shuyi Fang, Qiang Chen, Hong Liu, Jun Wan, Alexander L. Dent
View: Text | PDF
Research Article Immunology

Follicular regulatory T cells inhibit the development of granzyme B–expressing follicular helper T cells

  • Text
  • PDF
Abstract

T follicular regulatory (TFR) cells are found in the germinal center (GC) response and help shape the antibody (Ab) response. However, the precise role of TFR cells in the GC is controversial. Here, we addressed TFR cell function using mice with impaired TFR cell development (Bcl6-flox/Foxp3-cre, or Bcl6FC mice), mice with augmented TFR cell development (Blimp1-flox/Foxp3-cre, or Blimp1FC mice), and two different methods of immunization. Unexpectedly, GC B cell levels positively correlated with TFR cell levels. Using a gene profiling approach, we found that TFH cells from TFR-deficient mice showed strong upregulation of granzyme B (Gzmb) and other effector CD8+ T cell genes, many of which were Stat4 dependent. The upregulation of cytotoxic genes was the highest in TFH cells from TFR-deficient mice where Blimp1 was also deleted in Foxp3+ regulatory T cells (Bcl6-flox/Prdm1-flox/Foxp3-cre [DKO] mice). Granzyme B– and Eomesodermin-expressing TFH cells correlated with a higher rate of apoptotic GC B cells. Klrg1+ TFH cells from DKO mice expressed higher levels of Gzmb. Our data show that TFR cells repress the development of abnormal cytotoxic TFH cells, and the presence of cytotoxic TFH cells correlates with a lower GC and Ab response. Our data show what we believe is a novel mechanism of action for TFR cells helping the GC response.

Authors

Markus M. Xie, Shuyi Fang, Qiang Chen, Hong Liu, Jun Wan, Alexander L. Dent

×

Figure 4

Cytotoxic gene expression in TFH cells and increased GC B cell apoptosis in TFR-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Cytotoxic gene expression in TFH cells and increased GC B cell apoptosis...
Cytotoxic gene expression in TFH cells and increased GCB apoptosis in TFR-deficient mice. WT, Bcl6FC, Blimp1FC, and DKO mice were immunized with SRBCs and 9 days later, spleen cells were analyzed by flow cytometry for CD4+FOXP3–PD-1+CXCR5+ TFH cells and staining with (A) anti–granzyme B (Gzmb) Ab, (B) anti-Eomesodermin (Eomes) Ab, or (C) both Gzmb and Eomes Abs. Average Gzmb+ (A), Eomes+ (B), and Gzmb+Eomes+ (C) TFH cells are quantitated and graphed as a percentage of TFH cells, and absolute number. A total of 100,000 cells were analyzed by flow cytometry and TFH cells (0.5%–3%, 500–3,000) were gated for further analysis. n = 4; experiment was repeated 3 times. ANOVA with Tukey’s post hoc analysis was used to determine statistical significance.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts